EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE was reported 2950 times

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMACH SCAN ABNORMAL 5 0.1786
1 PARAPHIMOSIS 2 0.1053
2 BLOOD INSULIN 1 0.1000
3 HEPATOBILIARY PROCEDURAL COMPLICATION 2 0.0714
4 BASE EXCESS ABNORMAL 1 0.0714
5 SYNOVIAL DISORDER 25 0.0549
6 BIOPSY COLON 1 0.0417
7 INTESTINAL TRANSIT TIME ABNORMAL 2 0.0364
8 ALLERGIC SINUSITIS 25 0.0291
9 ALCOHOLIC KETOACIDOSIS 1 0.0256
10 URINE KETONE BODY 4 0.0245
11 ANAL FUNGAL INFECTION 2 0.0241
12 BALANITIS CANDIDA 3 0.0234
13 URINARY TRACT CANDIDIASIS 4 0.0209
14 FORCED EXPIRATORY FLOW DECREASED 2 0.0206
15 COMPLEMENT FACTOR C3 DECREASED 5 0.0205
16 PERINEAL INFECTION 4 0.0202
17 EUGLYCAEMIC DIABETIC KETOACIDOSIS 81 0.0196
18 KETONURIA 14 0.0172
19 KETOACIDOSIS 124 0.0166
20 NEUROSURGERY 3 0.0162
21 OLIGODIPSIA 3 0.0128
22 FOLLICULAR THYROID CANCER 2 0.0123
23 CHOLELITHIASIS OBSTRUCTIVE 2 0.0119
24 ACUTE HAEMORRHAGIC ULCERATIVE COLITIS 1 0.0116
25 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 2 0.0110
26 EMPHYSEMATOUS PYELONEPHRITIS 2 0.0109
27 COMPLEMENT FACTOR C4 DECREASED 2 0.0104
28 Q FEVER 2 0.0094
29 GENITAL CANDIDIASIS 2 0.0094
30 ANORECTAL SWELLING 2 0.0087
31 VITAMIN B12 DECREASED 25 0.0087
32 TYPE IIA HYPERLIPIDAEMIA 2 0.0085
33 URETHRAL PAIN 5 0.0085
34 ACQUIRED PHIMOSIS 1 0.0084
35 SCROTAL ABSCESS 3 0.0079
36 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
37 PANCREATIC NEOPLASM 9 0.0073
38 AUTONOMIC NEUROPATHY 7 0.0069
39 PERINEAL ABSCESS 3 0.0067
40 CATARRH 6 0.0066
41 DIABETIC KETOACIDOSIS 156 0.0065
42 BLOOD KETONE BODY 2 0.0058
43 BLOOD GLUCOSE 1 0.0056
44 BACTERIAL COLITIS 1 0.0056
45 ANAL FISSURE HAEMORRHAGE 1 0.0054
46 BLOOD ALKALINE PHOSPHATASE 1 0.0054
47 BLOOD KETONE BODY PRESENT 1 0.0053
48 URINARY TRACT INFECTION FUNGAL 3 0.0052
49 ATONIC URINARY BLADDER 1 0.0052
50 ASYMPTOMATIC COVID-19 2 0.0051
51 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 6 0.0050
52 BLOOD VISCOSITY INCREASED 3 0.0050
53 GENITAL INFECTION FUNGAL 4 0.0048
54 INSULIN RESISTANCE 10 0.0048
55 KETOSIS 5 0.0046
56 ACID BASE BALANCE ABNORMAL 1 0.0045
57 GASTROINTESTINAL HYPOMOTILITY 10 0.0044
58 BLOOD URIC ACID INCREASED 25 0.0043
59 EATING DISORDER SYMPTOM 2 0.0043
60 FEBRILE INFECTION 5 0.0042
61 SHOCK HYPOGLYCAEMIC 2 0.0042
62 PERIPHERAL ARTERY STENOSIS 2 0.0042
63 DIET REFUSAL 3 0.0041
64 ACETONAEMIA 1 0.0040
65 DEBRIDEMENT 3 0.0039
66 ORTHOPAEDIC PROCEDURE 2 0.0039
67 JOINT EFFUSION 26 0.0038
68 GLYCOSYLATED HAEMOGLOBIN DECREASED 6 0.0037
69 BALANOPOSTHITIS 3 0.0036
70 ENANTHEMA 2 0.0035
71 BACTERIAL VULVOVAGINITIS 1 0.0035
72 GENITAL BURNING SENSATION 3 0.0035
73 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
74 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
75 BACTERIAL TEST 1 0.0034
76 CANDIDA SEPSIS 3 0.0033
77 DIABETIC FOOT 10 0.0033
78 DRY GANGRENE 2 0.0031
79 ALLERGY TO ARTHROPOD BITE 1 0.0031
80 FORCED VITAL CAPACITY DECREASED 2 0.0031
81 BASAL GANGLIA INFARCTION 1 0.0029
82 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
83 IMPAIRED GASTRIC EMPTYING 38 0.0028
84 GENITAL PAIN 4 0.0027
85 ALKALOSIS 1 0.0026
86 BLOOD KETONE BODY INCREASED 2 0.0026
87 PRURITUS GENITAL 6 0.0025
88 LIMB MALFORMATION 2 0.0025
89 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
90 ANHIDROSIS 1 0.0025
91 BIOPSY LIVER 1 0.0024
92 AORTIC OCCLUSION 1 0.0024
93 PAPILLARY THYROID CANCER 4 0.0023
94 EXTREMITY NECROSIS 4 0.0023
95 BLOOD IRON DECREASED 27 0.0023
96 CYSTITIS HAEMORRHAGIC 9 0.0022
97 TOE AMPUTATION 11 0.0022
98 ADENOCARCINOMA GASTRIC 2 0.0022
99 SCROTAL SWELLING 2 0.0021
100 BLOOD CREATINE ABNORMAL 1 0.0021
101 PANCREATIC ENZYMES INCREASED 3 0.0020
102 MASTOIDITIS 2 0.0020
103 CYST 25 0.0020
104 MUCOSAL DISORDER 2 0.0020
105 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
106 POLYCYTHAEMIA 4 0.0019
107 URINE KETONE BODY PRESENT 3 0.0019
108 BLOOD GLUCOSE ABNORMAL 35 0.0019
109 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
110 ALBUMINURIA 1 0.0019
111 PANCREATIC MASS 2 0.0019
112 NAIL DISCOLOURATION 7 0.0018
113 FOOD AVERSION 3 0.0018
114 CORTISOL DECREASED 2 0.0017
115 CHEMICAL BURN 2 0.0017
116 THYROIDECTOMY 3 0.0017
117 RESTRICTIVE PULMONARY DISEASE 2 0.0017
118 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
119 TENDONITIS 26 0.0017
120 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
121 WEIGHT ABNORMAL 4 0.0017
122 POST-ACUTE COVID-19 SYNDROME 2 0.0016
123 LYMPH NODE PAIN 3 0.0016
124 AMPUTATION 2 0.0016
125 TESTICULAR PAIN 5 0.0016
126 BRONCHIAL SECRETION RETENTION 2 0.0016
127 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
128 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
129 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
130 BLOOD CHOLESTEROL ABNORMAL 7 0.0015
131 LACTIC ACIDOSIS 49 0.0015
132 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
133 GLYCOSURIA 2 0.0015
134 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
135 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
136 PRERENAL FAILURE 2 0.0014
137 INVESTIGATION ABNORMAL 2 0.0014
138 SYNOVITIS 25 0.0014
139 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
140 ATROPHIC VULVOVAGINITIS 1 0.0014
141 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
142 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
143 MYASTHENIA GRAVIS CRISIS 2 0.0013
144 BLISTER RUPTURE 1 0.0013
145 GASTROINTESTINAL WALL THICKENING 2 0.0013
146 GANGRENE 8 0.0013
147 RENAL COLIC 3 0.0013
148 FUNGAL INFECTION 44 0.0013
149 INJECTION SITE WARMTH 27 0.0013
150 PANCREATITIS CHRONIC 3 0.0013
151 LEG AMPUTATION 5 0.0012
152 DIABETIC NEUROPATHY 6 0.0012
153 INFLAMMATORY MARKER INCREASED 6 0.0012
154 ERUCTATION 23 0.0012
155 TYMPANIC MEMBRANE PERFORATION 2 0.0012
156 ACIDOSIS 9 0.0012
157 PHYSICAL DECONDITIONING 3 0.0012
158 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
159 SPINAL CORD INJURY 2 0.0011
160 ALOPECIA AREATA 2 0.0011
161 NECROTISING FASCIITIS 4 0.0011
162 HYPERLACTACIDAEMIA 3 0.0011
163 MONOPARESIS 2 0.0011
164 ULCERATIVE KERATITIS 3 0.0011
165 BODY TEMPERATURE ABNORMAL 2 0.0011
166 INFECTED SKIN ULCER 2 0.0011
167 BLOOD BICARBONATE DECREASED 2 0.0011
168 PANCREATIC CYST 2 0.0010
169 C-REACTIVE PROTEIN INCREASED 38 0.0010
170 FIBULA FRACTURE 3 0.0010
171 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
172 METABOLIC ACIDOSIS 33 0.0010
173 GALLBLADDER INJURY 2 0.0010
174 PYELONEPHRITIS ACUTE 2 0.0010
175 BLOOD GLUCOSE INCREASED 192 0.0010
176 PANCREATIC DISORDER 5 0.0010
177 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
178 POLYDIPSIA 4 0.0010
179 PROTEIN URINE PRESENT 5 0.0010
180 PROSTATITIS 3 0.0010
181 BENIGN BREAST NEOPLASM 1 0.0010
182 EYELID PAIN 2 0.0010
183 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
184 UROSEPSIS 9 0.0010
185 AXILLARY MASS 1 0.0010
186 MICROCYTIC ANAEMIA 2 0.0010
187 BLOOD GLUCOSE DECREASED 46 0.0010
188 FOOD CRAVING 5 0.0009
189 BLOOD LACTIC ACID INCREASED 5 0.0009
190 ACARODERMATITIS 1 0.0009
191 PARONYCHIA 4 0.0009
192 AORTIC DILATATION 1 0.0009
193 TEMPERATURE REGULATION DISORDER 2 0.0009
194 FEAR OF DEATH 2 0.0009
195 SUSPECTED OFF LABEL USE 4 0.0009
196 DIABETIC RETINOPATHY 3 0.0009
197 BRAIN OPERATION 2 0.0009
198 MICTURITION DISORDER 3 0.0009
199 BLOOD POTASSIUM INCREASED 14 0.0009
200 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
201 DISCOURAGEMENT 2 0.0009
202 CARDIAC PACEMAKER INSERTION 5 0.0008
203 WRONG DOSE 2 0.0008
204 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
205 ILEUS 10 0.0008
206 INJECTION SITE INFLAMMATION 4 0.0008
207 BLADDER DISCOMFORT 1 0.0008
208 HYPERGLYCAEMIA 29 0.0008
209 TONGUE OEDEMA 3 0.0008
210 THYROID MASS 3 0.0008
211 MEAN CELL VOLUME INCREASED 2 0.0008
212 ADENOCARCINOMA PANCREAS 1 0.0008
213 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
214 DRUG TITRATION ERROR 2 0.0008
215 HYPERSENSITIVITY VASCULITIS 2 0.0008
216 ACROCHORDON 1 0.0008
217 RENAL DISORDER 35 0.0008
218 NOCTURIA 9 0.0007
219 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
220 BLOOD GLUCOSE FLUCTUATION 8 0.0007
221 PROSTATIC DISORDER 4 0.0007
222 NERVE INJURY 8 0.0007
223 ACUTE PULMONARY OEDEMA 4 0.0007
224 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
225 AUDITORY DISORDER 1 0.0007
226 TUMOUR HAEMORRHAGE 2 0.0007
227 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
228 CARDIAC OPERATION 6 0.0007
229 VASCULAR GRAFT 2 0.0007
230 VOMITING PROJECTILE 2 0.0007
231 DYSPNOEA AT REST 2 0.0007
232 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
233 SKIN WARM 4 0.0007
234 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
235 ACUTE ABDOMEN 1 0.0007
236 CARDIOTOXICITY 6 0.0007
237 ILEUS PARALYTIC 3 0.0007
238 BLOOD CULTURE POSITIVE 2 0.0007
239 HYDRONEPHROSIS 5 0.0007
240 PANCREATITIS ACUTE 15 0.0007
241 THYROIDITIS 2 0.0007
242 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
243 CRANIOCEREBRAL INJURY 2 0.0007
244 OSTEOARTHRITIS 28 0.0007
245 HAEMOGLOBIN INCREASED 3 0.0007
246 RECTAL CANCER 2 0.0007
247 DIASTOLIC DYSFUNCTION 2 0.0006
248 HYPOGLYCAEMIA 31 0.0006
249 SKIN ABRASION 3 0.0006
250 NEPHROLITHIASIS 29 0.0006
251 PROCTALGIA 4 0.0006
252 THIRST 11 0.0006
253 POSTURE ABNORMAL 2 0.0006
254 POLYURIA 5 0.0006
255 APPETITE DISORDER 4 0.0006
256 HYPERNATRAEMIA 3 0.0006
257 POLLAKIURIA 25 0.0006
258 PROSTATE CANCER METASTATIC 2 0.0006
259 VULVOVAGINAL PRURITUS 3 0.0006
260 HYPOPHAGIA 15 0.0006
261 BLADDER NEOPLASM 1 0.0006
262 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
263 MYOPATHY 5 0.0006
264 CAROTID ARTERY STENOSIS 2 0.0006
265 EAR PRURITUS 2 0.0006
266 RENAL PAIN 6 0.0006
267 SUBDURAL HAEMATOMA 8 0.0006
268 OEDEMA 30 0.0006
269 DERMATITIS BULLOUS 4 0.0006
270 GASTROENTERITIS 8 0.0005
271 AMYLASE INCREASED 2 0.0005
272 PANCREATITIS 28 0.0005
273 SEPSIS 59 0.0005
274 PARANASAL SINUS HYPERSECRETION 2 0.0005
275 ARTERIAL DISORDER 1 0.0005
276 LIPASE INCREASED 4 0.0005
277 HERPES VIRUS INFECTION 3 0.0005
278 ATRIOVENTRICULAR BLOCK 4 0.0005
279 METABOLIC DISORDER 3 0.0005
280 WEIGHT DECREASED 144 0.0005
281 TACHYPNOEA 7 0.0005
282 ALCOHOL INTERACTION 1 0.0005
283 HYPOVOLAEMIA 3 0.0005
284 URINARY RETENTION 17 0.0005
285 PROSTATOMEGALY 2 0.0005
286 DECREASED INTEREST 3 0.0005
287 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
288 ERECTILE DYSFUNCTION 13 0.0005
289 LIGAMENT SPRAIN 5 0.0005
290 ARTHROPATHY 28 0.0005
291 HYPERPHAGIA 2 0.0005
292 HEPATIC ENZYME INCREASED 34 0.0005
293 URINARY TRACT INFECTION 85 0.0005
294 OSTEOMYELITIS 9 0.0005
295 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 23 0.0005
296 RECURRENT CANCER 2 0.0005
297 PERIPHERAL ISCHAEMIA 2 0.0005
298 TRIGGER FINGER 2 0.0005
299 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
300 ANAPHYLACTOID REACTION 2 0.0005
301 PIGMENTATION DISORDER 3 0.0005
302 POOR VENOUS ACCESS 5 0.0005
303 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
304 PHOTOPHOBIA 9 0.0005
305 WEIGHT FLUCTUATION 5 0.0005
306 FLATULENCE 27 0.0005
307 THROAT CANCER 2 0.0005
308 POOR PERIPHERAL CIRCULATION 2 0.0005
309 PRODUCT DISPENSING ISSUE 2 0.0005
310 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
311 PYELONEPHRITIS 4 0.0005
312 DIVERTICULUM INTESTINAL 2 0.0005
313 HYPERKALAEMIA 16 0.0005
314 DYSPHEMIA 2 0.0005
315 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
316 ADENOCARCINOMA 1 0.0004
317 LOSS OF LIBIDO 4 0.0004
318 EXTRA DOSE ADMINISTERED 18 0.0004
319 LIMB INJURY 12 0.0004
320 VASCULAR DEVICE INFECTION 2 0.0004
321 LABORATORY TEST ABNORMAL 13 0.0004
322 NERVE COMPRESSION 4 0.0004
323 HYPERTRANSAMINASAEMIA 3 0.0004
324 ELECTROLYTE IMBALANCE 5 0.0004
325 BACTERIAL INFECTION 8 0.0004
326 BILIRUBIN CONJUGATED INCREASED 1 0.0004
327 VAGINAL INFECTION 2 0.0004
328 INTESTINAL OBSTRUCTION 16 0.0004
329 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
330 EATING DISORDER 9 0.0004
331 DEHYDRATION 56 0.0004
332 PRODUCT PRESCRIBING ERROR 10 0.0004
333 CHOLECYSTITIS 5 0.0004
334 ACUTE KIDNEY INJURY 64 0.0004
335 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
336 FAECES SOFT 3 0.0004
337 INTENTIONAL UNDERDOSE 3 0.0004
338 BLINDNESS TRANSIENT 3 0.0004
339 PSYCHIATRIC SYMPTOM 3 0.0004
340 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
341 VOMITING 189 0.0004
342 VEIN DISORDER 2 0.0004
343 VAGINAL DISCHARGE 4 0.0004
344 TROPONIN INCREASED 3 0.0004
345 DYSLIPIDAEMIA 2 0.0004
346 HAEMODYNAMIC INSTABILITY 3 0.0004
347 DIABETES MELLITUS 30 0.0004
348 APPENDICITIS PERFORATED 1 0.0004
349 GOUT 7 0.0004
350 TORSADE DE POINTES 3 0.0004
351 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
352 PRODUCT ODOUR ABNORMAL 4 0.0004
353 ARTHRITIS 30 0.0004
354 DYSURIA 14 0.0004
355 DECREASED APPETITE 88 0.0004
356 ULCER 6 0.0004
357 CONSTIPATION 82 0.0004
358 ATRIAL FLUTTER 3 0.0004
359 STENT PLACEMENT 3 0.0004
360 POOR QUALITY SLEEP 8 0.0004
361 ANAL ABSCESS 2 0.0004
362 PRODUCT RESIDUE PRESENT 2 0.0004
363 BACK DISORDER 6 0.0004
364 ANORGASMIA 1 0.0004
365 DECUBITUS ULCER 3 0.0004
366 INCREASED APPETITE 7 0.0004
367 DEAFNESS UNILATERAL 2 0.0004
368 VENTRICULAR FIBRILLATION 4 0.0004
369 HYPOMAGNESAEMIA 5 0.0004
370 ANAL HAEMORRHAGE 1 0.0004
371 MACULAR OEDEMA 2 0.0004
372 CANDIDA INFECTION 6 0.0004
373 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
374 BLOOD PRESSURE ABNORMAL 7 0.0004
375 ANURIA 3 0.0003
376 HYPOKALAEMIA 16 0.0003
377 HYPERVENTILATION 2 0.0003
378 RALES 2 0.0003
379 SPINAL PAIN 4 0.0003
380 COVID-19 PNEUMONIA 4 0.0003
381 INJECTION SITE VESICLES 2 0.0003
382 OPTIC NEURITIS 3 0.0003
383 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
384 MENISCUS INJURY 2 0.0003
385 IRON DEFICIENCY ANAEMIA 3 0.0003
386 INJECTION SITE EXTRAVASATION 4 0.0003
387 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
388 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
389 PRODUCT DISPENSING ERROR 7 0.0003
390 INFUSION SITE EXTRAVASATION 2 0.0003
391 DEFORMITY 3 0.0003
392 PRE-EXISTING CONDITION IMPROVED 2 0.0003
393 SWELLING OF EYELID 2 0.0003
394 INFUSION RELATED REACTION 21 0.0003
395 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
396 MUSCLE ATROPHY 4 0.0003
397 BLADDER PAIN 1 0.0003
398 SLEEP APNOEA SYNDROME 6 0.0003
399 ABSCESS 5 0.0003
400 ENTERITIS 2 0.0003
401 ROTATOR CUFF SYNDROME 4 0.0003
402 HAEMOGLOBIN ABNORMAL 2 0.0003
403 CARDIAC FLUTTER 2 0.0003
404 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
405 BACTERIAL SEPSIS 1 0.0003
406 BLOOD CREATININE INCREASED 20 0.0003
407 PSORIASIS 40 0.0003
408 BRADYPHRENIA 2 0.0003
409 JOINT STIFFNESS 8 0.0003
410 PULMONARY CONGESTION 4 0.0003
411 CORONAVIRUS INFECTION 2 0.0003
412 INABILITY TO AFFORD MEDICATION 3 0.0003
413 ABDOMINAL PAIN UPPER 62 0.0003
414 BRAIN INJURY 3 0.0003
415 POST-TRAUMATIC STRESS DISORDER 2 0.0003
416 INJECTION SITE MASS 11 0.0003
417 EMPHYSEMA 3 0.0003
418 METASTASES TO LYMPH NODES 2 0.0003
419 SINUS CONGESTION 4 0.0003
420 WRONG PRODUCT ADMINISTERED 2 0.0003
421 TASTE DISORDER 6 0.0003
422 B-CELL LYMPHOMA 1 0.0003
423 ABNORMAL LOSS OF WEIGHT 2 0.0003
424 NEUTROPHIL COUNT INCREASED 3 0.0003
425 ONYCHOCLASIS 2 0.0003
426 BLOOD CREATININE ABNORMAL 1 0.0003
427 LARGE INTESTINE POLYP 2 0.0003
428 DIVERTICULITIS 8 0.0003
429 DEVICE DEFECTIVE 5 0.0003
430 AUTOIMMUNE HEPATITIS 2 0.0003
431 EXTRASYSTOLES 2 0.0003
432 MASS 4 0.0003
433 DEFAECATION URGENCY 2 0.0003
434 INJECTION SITE DISCOMFORT 3 0.0003
435 MOUTH ULCERATION 6 0.0003
436 COLD SWEAT 5 0.0003
437 DUODENAL ULCER 2 0.0003
438 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
439 DIVERTICULUM 2 0.0003
440 AGEUSIA 7 0.0003
441 HEREDITARY ANGIOEDEMA 3 0.0003
442 AMNESIA 18 0.0003
443 SKIN LACERATION 3 0.0003
444 ABDOMINAL PAIN 64 0.0003
445 ABDOMINAL DISCOMFORT 46 0.0003
446 INJECTION SITE NODULE 3 0.0003
447 ILLNESS 28 0.0003
448 INCORRECT DOSE ADMINISTERED 62 0.0003
449 ACUTE MYOCARDIAL INFARCTION 8 0.0003
450 FEELING DRUNK 2 0.0003
451 NAUSEA 213 0.0003
452 MALNUTRITION 3 0.0003
453 NERVOUSNESS 14 0.0003
454 MIDDLE INSOMNIA 5 0.0003
455 BLOOD CALCIUM DECREASED 3 0.0003
456 JOINT SWELLING 32 0.0003
457 PEMPHIGOID 2 0.0003
458 AUTOIMMUNE THYROIDITIS 1 0.0003
459 HYPOCALCAEMIA 5 0.0003
460 FOOT FRACTURE 5 0.0003
461 BLOOD URINE PRESENT 5 0.0003
462 COVID-19 46 0.0003
463 INSURANCE ISSUE 4 0.0003
464 BOWEL MOVEMENT IRREGULARITY 2 0.0003
465 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
466 LYMPHOMA 4 0.0003
467 HERNIA 5 0.0003
468 APHTHOUS ULCER 2 0.0003
469 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
470 SEPTIC SHOCK 11 0.0003
471 BACTERAEMIA 3 0.0003
472 RENAL CYST 2 0.0003
473 SCIATICA 4 0.0003
474 LOCALISED INFECTION 6 0.0002
475 MYASTHENIA GRAVIS 2 0.0002
476 FRUSTRATION TOLERANCE DECREASED 2 0.0002
477 POST PROCEDURAL INFECTION 2 0.0002
478 BLINDNESS 10 0.0002
479 DIARRHOEA 158 0.0002
480 ANGINA PECTORIS 7 0.0002
481 HICCUPS 2 0.0002
482 ESCHERICHIA INFECTION 2 0.0002
483 PANCREATIC CARCINOMA 7 0.0002
484 INJECTION SITE DISCOLOURATION 3 0.0002
485 EOSINOPHIL COUNT INCREASED 2 0.0002
486 PEMPHIGUS 3 0.0002
487 RHABDOMYOLYSIS 10 0.0002
488 GAIT INABILITY 8 0.0002
489 NASAL CONGESTION 14 0.0002
490 PRODUCT DOSE OMISSION ISSUE 70 0.0002
491 SENSATION OF FOREIGN BODY 2 0.0002
492 INFUSION SITE ERYTHEMA 2 0.0002
493 URINARY INCONTINENCE 7 0.0002
494 ABSCESS LIMB 1 0.0002
495 FACIAL PARALYSIS 2 0.0002
496 RETCHING 5 0.0002
497 VITAMIN D DECREASED 2 0.0002
498 SCAR 4 0.0002
499 ALCOHOLISM 1 0.0002
500 DRUG INTERACTION 37 0.0002
501 GASTRIC DISORDER 8 0.0002
502 BLOOD POTASSIUM DECREASED 7 0.0002
503 ABNORMAL SENSATION IN EYE 1 0.0002
504 MUSCULOSKELETAL DISCOMFORT 4 0.0002
505 SKIN ULCER 6 0.0002
506 INJECTION SITE INDURATION 3 0.0002
507 ASTHENIA 87 0.0002
508 CARDIAC MURMUR 2 0.0002
509 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
510 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
511 URINE OUTPUT DECREASED 2 0.0002
512 INTENTIONAL PRODUCT MISUSE 20 0.0002
513 GROIN PAIN 2 0.0002
514 ANKYLOSING SPONDYLITIS 3 0.0002
515 SARS-COV-2 TEST POSITIVE 3 0.0002
516 LIMB DISCOMFORT 7 0.0002
517 RENAL IMPAIRMENT 19 0.0002
518 PURPURA 2 0.0002
519 BLOOD PRESSURE DECREASED 15 0.0002
520 RESPIRATORY RATE INCREASED 2 0.0002
521 EYE HAEMORRHAGE 3 0.0002
522 PAIN IN EXTREMITY 66 0.0002
523 DYSPEPSIA 22 0.0002
524 GASTROINTESTINAL INFECTION 2 0.0002
525 MYOSITIS 2 0.0002
526 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
527 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
528 OROPHARYNGEAL DISCOMFORT 2 0.0002
529 DRY EYE 11 0.0002
530 ACCIDENTAL OVERDOSE 8 0.0002
531 DIZZINESS 109 0.0002
532 RETINAL DETACHMENT 2 0.0002
533 NIGHT SWEATS 7 0.0002
534 HUNGER 3 0.0002
535 CHEST DISCOMFORT 22 0.0002
536 HEPATIC ENCEPHALOPATHY 2 0.0002
537 CARPAL TUNNEL SYNDROME 3 0.0002
538 CHOLELITHIASIS 7 0.0002
539 HEPATIC CIRRHOSIS 4 0.0002
540 ARTERIOSCLEROSIS 2 0.0002
541 SPINAL DISORDER 2 0.0002
542 BRONCHOSPASM 3 0.0002
543 RECALLED PRODUCT ADMINISTERED 2 0.0002
544 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
545 ACCIDENTAL UNDERDOSE 3 0.0002
546 POST PROCEDURAL COMPLICATION 4 0.0002
547 TYPE 2 DIABETES MELLITUS 7 0.0002
548 INJECTION SITE PAIN 63 0.0002
549 SKIN FISSURES 4 0.0002
550 INJECTION SITE URTICARIA 5 0.0002
551 KNEE OPERATION 2 0.0002
552 APPLICATION SITE BURN 1 0.0002
553 HOSPICE CARE 2 0.0002
554 DISABILITY 4 0.0002
555 ABDOMINAL DISTENSION 21 0.0002
556 PRESCRIBED UNDERDOSE 4 0.0002
557 HYPOTENSION 40 0.0002
558 HOT FLUSH 15 0.0002
559 ECONOMIC PROBLEM 3 0.0002
560 DRY MOUTH 16 0.0002
561 DISCOMFORT 12 0.0002
562 SUBARACHNOID HAEMORRHAGE 2 0.0002
563 SKIN DISCOLOURATION 9 0.0002
564 INITIAL INSOMNIA 2 0.0002
565 DEVICE RELATED INFECTION 3 0.0002
566 PERIPHERAL SWELLING 30 0.0002
567 VISUAL IMPAIRMENT 24 0.0002
568 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
569 TREMOR 32 0.0002
570 VENTRICULAR EXTRASYSTOLES 2 0.0002
571 BASAL CELL CARCINOMA 3 0.0002
572 NERVOUS SYSTEM DISORDER 6 0.0002
573 BRAIN FOG 3 0.0002
574 TRANSFUSION 2 0.0002
575 PYREXIA 66 0.0002
576 HALLUCINATION, VISUAL 4 0.0002
577 MEMORY IMPAIRMENT 26 0.0002
578 INCONTINENCE 2 0.0002
579 JOINT DISLOCATION 2 0.0002
580 EAR INFECTION 5 0.0002
581 SURGERY 11 0.0002
582 ANAL FISTULA 1 0.0002
583 JOINT INJURY 4 0.0002
584 FEAR 5 0.0002
585 HYPOACUSIS 8 0.0002
586 RHINORRHOEA 12 0.0002
587 MUSCLE TIGHTNESS 3 0.0002
588 MUSCULAR WEAKNESS 21 0.0002
589 CATARACT 11 0.0002
590 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
591 BIPOLAR DISORDER 2 0.0002
592 OESOPHAGITIS 2 0.0002
593 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
594 ASPIRATION 2 0.0002
595 ASTHENOPIA 1 0.0002
596 ANAPHYLACTIC REACTION 10 0.0002
597 FOOT DEFORMITY 2 0.0002
598 TRANSAMINASES INCREASED 4 0.0002
599 NEOPLASM MALIGNANT 12 0.0002
600 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
601 HYPERTENSIVE CRISIS 2 0.0002
602 LOSS OF CONSCIOUSNESS 23 0.0002
603 BLOOD UREA INCREASED 3 0.0002
604 HYPERHIDROSIS 23 0.0002
605 ANGIOPATHY 1 0.0002
606 RESPIRATORY FAILURE 13 0.0002
607 CHEST PAIN 33 0.0002
608 FACE OEDEMA 3 0.0002
609 STATUS EPILEPTICUS 2 0.0002
610 REBOUND EFFECT 2 0.0002
611 ARTHRALGIA 73 0.0002
612 DERMATITIS CONTACT 2 0.0002
613 MYOCARDITIS 2 0.0002
614 SHOCK 4 0.0002
615 METASTASES TO LUNG 2 0.0002
616 BLOOD CHOLESTEROL INCREASED 8 0.0002
617 FALL 57 0.0002
618 MUSCULOSKELETAL STIFFNESS 15 0.0002
619 EOSINOPHILIA 3 0.0002
620 CEREBROVASCULAR ACCIDENT 29 0.0002
621 BURNING SENSATION 12 0.0002
622 SEXUAL DYSFUNCTION 2 0.0002
623 SLEEP DISORDER 12 0.0002
624 RASH 74 0.0002
625 WEIGHT INCREASED 38 0.0002
626 FATIGUE 131 0.0002
627 DISEASE RECURRENCE 8 0.0002
628 MACULAR DEGENERATION 2 0.0002
629 GASTROINTESTINAL DISORDER 15 0.0002
630 HYPERLIPIDAEMIA 2 0.0002
631 DEVICE ISSUE 15 0.0002
632 POLYNEUROPATHY 2 0.0002
633 BLOOD PRESSURE FLUCTUATION 4 0.0002
634 APHASIA 5 0.0002
635 LACRIMATION INCREASED 5 0.0002
636 CORONARY ARTERY DISEASE 5 0.0002
637 RESTLESS LEGS SYNDROME 3 0.0002
638 BONE DISORDER 3 0.0002
639 SCHIZOPHRENIA 2 0.0002
640 NEURALGIA 4 0.0002
641 TREATMENT NONCOMPLIANCE 9 0.0002
642 INJECTION SITE RASH 5 0.0002
643 MUSCLE SPASTICITY 2 0.0002
644 SMALL INTESTINAL OBSTRUCTION 2 0.0002
645 DEVICE LEAKAGE 7 0.0002
646 SECRETION DISCHARGE 2 0.0002
647 BLOOD SODIUM DECREASED 3 0.0002
648 DERMATITIS ALLERGIC 2 0.0002
649 HEAD INJURY 5 0.0002
650 INJECTION SITE IRRITATION 2 0.0002
651 HEPATITIS 4 0.0002
652 CHOLESTASIS 3 0.0002
653 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
654 ACUTE RESPIRATORY FAILURE 3 0.0002
655 SEIZURE 18 0.0002
656 HYPERTENSION 33 0.0002
657 GLAUCOMA 3 0.0002
658 MALAISE 68 0.0002
659 HAEMORRHOIDS 3 0.0002
660 CHOKING 3 0.0002
661 HYPOAESTHESIA 23 0.0002
662 ECZEMA 8 0.0002
663 BEDRIDDEN 2 0.0002
664 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
665 HEART RATE INCREASED 15 0.0002
666 SOPOR 2 0.0002
667 BACK PAIN 35 0.0002
668 RENAL FAILURE 20 0.0002
669 UPPER LIMB FRACTURE 3 0.0002
670 INJECTION SITE BRUISING 12 0.0002
671 INJECTION SITE HAEMORRHAGE 12 0.0002
672 CARDIAC FAILURE 12 0.0001
673 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
674 JOINT RANGE OF MOTION DECREASED 2 0.0001
675 BRONCHITIS 11 0.0001
676 PRODUCT ADMINISTRATION ERROR 3 0.0001
677 FREQUENT BOWEL MOVEMENTS 4 0.0001
678 CONDITION AGGRAVATED 45 0.0001
679 FEEDING DISORDER 3 0.0001
680 PSORIATIC ARTHROPATHY 6 0.0001
681 PRODUCT TASTE ABNORMAL 2 0.0001
682 RASH PRURITIC 8 0.0001
683 DYSPHAGIA 14 0.0001
684 UVEITIS 2 0.0001
685 NEUROPATHY PERIPHERAL 14 0.0001
686 MYALGIA 25 0.0001
687 COMA 7 0.0001
688 PRODUCTIVE COUGH 7 0.0001
689 PARAESTHESIA 23 0.0001
690 HAEMATURIA 5 0.0001
691 RIB FRACTURE 3 0.0001
692 CORONARY ARTERY OCCLUSION 2 0.0001
693 MENTAL STATUS CHANGES 4 0.0001
694 DERMATITIS 3 0.0001
695 DEMENTIA 4 0.0001
696 BLINDNESS UNILATERAL 2 0.0001
697 PAIN 87 0.0001
698 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
699 DIALYSIS 2 0.0001
700 SINUS TACHYCARDIA 2 0.0001
701 PLATELET COUNT DECREASED 15 0.0001
702 OROPHARYNGEAL PAIN 13 0.0001
703 INTENTIONAL OVERDOSE 9 0.0001
704 LEUKOPENIA 7 0.0001
705 RECTAL HAEMORRHAGE 6 0.0001
706 CARDIOGENIC SHOCK 2 0.0001
707 IMPAIRED QUALITY OF LIFE 2 0.0001
708 LETHARGY 8 0.0001
709 CELLULITIS 7 0.0001
710 PRURITUS GENERALISED 3 0.0001
711 FAECES DISCOLOURED 3 0.0001
712 ANOSMIA 2 0.0001
713 HYPERTHYROIDISM 2 0.0001
714 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
715 PRODUCT PRESCRIBING ISSUE 3 0.0001
716 BLOOD PRESSURE INCREASED 21 0.0001
717 APATHY 2 0.0001
718 DYSSTASIA 4 0.0001
719 CARDIAC FAILURE CONGESTIVE 11 0.0001
720 CONFUSIONAL STATE 22 0.0001
721 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
722 SKIN HAEMORRHAGE 2 0.0001
723 ARTHROPOD BITE 1 0.0001
724 RASH MACULO-PAPULAR 3 0.0001
725 PULMONARY MASS 2 0.0001
726 SOMNOLENCE 27 0.0001
727 ORAL PAIN 3 0.0001
728 THROAT IRRITATION 6 0.0001
729 ATRIAL FIBRILLATION 13 0.0001
730 MYOCARDIAL INFARCTION 23 0.0001
731 DEVICE FAILURE 2 0.0001
732 DISTURBANCE IN ATTENTION 7 0.0001
733 ANKLE FRACTURE 2 0.0001
734 FEMUR FRACTURE 4 0.0001
735 EJECTION FRACTION DECREASED 2 0.0001
736 APNOEA 1 0.0001
737 HEADACHE 80 0.0001
738 CYANOSIS 2 0.0001
739 DISORIENTATION 5 0.0001
740 MEDICATION ERROR 7 0.0001
741 THERAPY INTERRUPTED 9 0.0001
742 INFLUENZA 14 0.0001
743 RASH ERYTHEMATOUS 6 0.0001
744 HYPOTHYROIDISM 4 0.0001
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
746 MOVEMENT DISORDER 4 0.0001
747 OXYGEN SATURATION DECREASED 7 0.0001
748 HIP FRACTURE 4 0.0001
749 HYPONATRAEMIA 7 0.0001
750 MENTAL IMPAIRMENT 3 0.0001
751 SWELLING FACE 8 0.0001
752 ASPHYXIA 1 0.0001
753 ENCEPHALOPATHY 3 0.0001
754 ABNORMAL FAECES 1 0.0001
755 IMPAIRED HEALING 4 0.0001
756 ACUTE CORONARY SYNDROME 1 0.0001
757 EXPIRED PRODUCT ADMINISTERED 4 0.0001
758 LIP SWELLING 4 0.0001
759 INJECTION SITE PRURITUS 8 0.0001
760 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
761 ABDOMINAL PAIN LOWER 3 0.0001
762 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
763 SKIN EXFOLIATION 10 0.0001
764 HAEMATEMESIS 3 0.0001
765 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
766 CARDIAC DISORDER 11 0.0001
767 ANAPHYLACTIC SHOCK 3 0.0001
768 OFF LABEL USE 101 0.0001
769 RESPIRATORY TRACT INFECTION 3 0.0001
770 SEDATION 3 0.0001
771 RASH MACULAR 4 0.0001
772 DEVICE USE ISSUE 2 0.0001
773 FEELING HOT 7 0.0001
774 BLOOD CALCIUM INCREASED 1 0.0001
775 GASTRITIS 3 0.0001
776 HEART RATE DECREASED 4 0.0001
777 DEPRESSED MOOD 6 0.0001
778 ANGIOEDEMA 5 0.0001
779 HEAD DISCOMFORT 2 0.0001
780 DRUG ERUPTION 2 0.0001
781 LIVER DISORDER 5 0.0001
782 FEELING ABNORMAL 27 0.0001
783 INSOMNIA 30 0.0001
784 TACHYCARDIA 10 0.0001
785 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
786 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
787 ISCHAEMIC STROKE 2 0.0001
788 GALLBLADDER DISORDER 2 0.0001
789 CEREBRAL HAEMORRHAGE 4 0.0001
790 JAUNDICE 3 0.0001
791 MOBILITY DECREASED 8 0.0001
792 PNEUMONIA 36 0.0001
793 ANAL INCONTINENCE 1 0.0001
794 PALPITATIONS 13 0.0001
795 THROAT TIGHTNESS 3 0.0001
796 GASTROENTERITIS VIRAL 2 0.0001
797 COUGH 31 0.0001
798 PNEUMONITIS 3 0.0001
799 GAIT DISTURBANCE 21 0.0001
800 END STAGE RENAL DISEASE 2 0.0001
801 PRURITUS 42 0.0001
802 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
803 CARDIAC ARREST 9 0.0001
804 PROCEDURAL PAIN 3 0.0001
805 DEEP VEIN THROMBOSIS 7 0.0001
806 DYSGEUSIA 8 0.0001
807 HAEMOPTYSIS 3 0.0001
808 HEPATIC STEATOSIS 2 0.0001
809 PANCYTOPENIA 6 0.0001
810 EYE PAIN 6 0.0001
811 ABORTION INDUCED 1 0.0001
812 ASTHMA 12 0.0001
813 DYSPNOEA 60 0.0001
814 FRACTURE 2 0.0001
815 ARRHYTHMIA 5 0.0001
816 OCULAR HYPERAEMIA 5 0.0001
817 PROTEINURIA 2 0.0001
818 HYPERSOMNIA 3 0.0001
819 PRODUCT SUBSTITUTION ISSUE 6 0.0001
820 BALANCE DISORDER 9 0.0001
821 AFFECT LABILITY 1 0.0001
822 INFECTION 15 0.0001
823 DRUG INTOLERANCE 10 0.0001
824 NASOPHARYNGITIS 19 0.0001
825 AUTOIMMUNE DISORDER 1 0.0001
826 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
827 VISION BLURRED 14 0.0001
828 PSYCHOTIC DISORDER 3 0.0001
829 SINUS DISORDER 2 0.0001
830 IRRITABILITY 6 0.0001
831 FULL BLOOD COUNT DECREASED 2 0.0001
832 PLEURAL EFFUSION 6 0.0001
833 OEDEMA PERIPHERAL 12 0.0001
834 BODY TEMPERATURE INCREASED 2 0.0001
835 SINUSITIS 10 0.0001
836 THERAPY CESSATION 5 0.0001
837 INFLAMMATION 5 0.0001
838 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
839 DRUG-INDUCED LIVER INJURY 3 0.0001
840 KNEE ARTHROPLASTY 2 0.0001
841 DERMATITIS ATOPIC 5 0.0001
842 CYSTITIS 3 0.0001
843 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
844 CHILLS 11 0.0001
845 LIVER FUNCTION TEST INCREASED 2 0.0001
846 MUSCLE SPASMS 17 0.0001
847 DEPRESSION 21 0.0001
848 MENTAL DISORDER 4 0.0001
849 INJECTION SITE SWELLING 7 0.0001
850 EYE DISORDER 3 0.0001
851 STAPHYLOCOCCAL INFECTION 3 0.0001
852 MELAENA 2 0.0001
853 VISUAL ACUITY REDUCED 3 0.0001
854 VIRAL INFECTION 3 0.0001
855 DRY SKIN 12 0.0001
856 NECK PAIN 5 0.0001
857 PULMONARY OEDEMA 4 0.0001
858 SNEEZING 2 0.0001
859 DRUG INEFFECTIVE 117 0.0001
860 INJECTION SITE ERYTHEMA 11 0.0001
861 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
862 PRODUCT AVAILABILITY ISSUE 2 0.0001
863 INJECTION SITE REACTION 6 0.0001
864 TINNITUS 4 0.0001
865 NIGHTMARE 3 0.0001
866 DEVICE USE ERROR 3 0.0001
867 SWELLING 8 0.0001
868 HYPOXIA 3 0.0001
869 BLADDER CANCER 5 0.0001
870 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
871 ACCIDENT 1 0.0001
872 URTICARIA 14 0.0001
873 HEPATIC CANCER 2 0.0001
874 SUICIDE ATTEMPT 5 0.0001
875 ADRENAL INSUFFICIENCY 1 0.0001
876 ILL-DEFINED DISORDER 5 0.0001
877 PRESYNCOPE 2 0.0001
878 VERTIGO 5 0.0001
879 SYNCOPE 8 0.0001
880 DYSPNOEA EXERTIONAL 3 0.0001
881 ACNE 6 0.0001
882 PRODUCT COMPLAINT 2 0.0001
883 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
884 ERYTHEMA 16 0.0001
885 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
886 ANXIETY 22 0.0001
887 EXPOSURE VIA SKIN CONTACT 2 0.0001
888 DIPLOPIA 2 0.0001
889 ALOPECIA 15 0.0001
890 ANHEDONIA 2 0.0001
891 THROMBOSIS 6 0.0001
892 BLOOD BILIRUBIN INCREASED 2 0.0001
893 PRODUCT QUALITY ISSUE 10 0.0001
894 PALLOR 2 0.0001
895 MIGRAINE 7 0.0001
896 ACUTE HEPATIC FAILURE 1 0.0001
897 LUNG NEOPLASM MALIGNANT 3 0.0001
898 CONTUSION 7 0.0001
899 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
900 ROAD TRAFFIC ACCIDENT 3 0.0001
901 APHONIA 1 0.0001
902 WOUND 2 0.0001
903 PAIN IN JAW 2 0.0001
904 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
905 PRODUCT USE ISSUE 13 0.0001
906 VAGINAL HAEMORRHAGE 3 0.0001
907 LIVER FUNCTION TEST ABNORMAL 2 0.0001
908 UNDERDOSE 5 0.0001
909 DYSPHONIA 4 0.0001
910 BONE PAIN 4 0.0001
911 ANAEMIA 13 0.0001
912 AGITATION 5 0.0001
913 ASCITES 2 0.0001
914 OESOPHAGEAL CARCINOMA 2 0.0001
915 COLITIS ULCERATIVE 3 0.0001
916 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
917 HALLUCINATION 5 0.0001
918 HEPATIC FAILURE 2 0.0001
919 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
920 BLOOD COUNT ABNORMAL 1 0.0001
921 CHRONIC KIDNEY DISEASE 5 0.0001
922 SUICIDAL IDEATION 6 0.0001
923 SKIN IRRITATION 3 0.0001
924 HOSPITALISATION 10 0.0001
925 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
926 COGNITIVE DISORDER 3 0.0001
927 RENAL CANCER 3 0.0001
928 INFLUENZA LIKE ILLNESS 5 0.0001
929 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
930 SKIN DISORDER 2 0.0001
931 AGGRESSION 3 0.0001
932 EYE PRURITUS 2 0.0001
933 HYPERSENSITIVITY 11 0.0001
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
935 ANGER 2 0.0001
936 FLUSHING 6 0.0001
937 DELIRIUM 2 0.0001
938 HAEMORRHAGE 6 0.0001
939 MUSCULOSKELETAL PAIN 3 0.0001
940 SPEECH DISORDER 3 0.0001
941 PRODUCT STORAGE ERROR 5 0.0001
942 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
943 LYMPHADENOPATHY 2 0.0001
944 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
945 OVERDOSE 12 0.0001
946 CRYING 2 0.0001
947 HAEMATOCHEZIA 3 0.0001
948 AGRANULOCYTOSIS 1 0.0001
949 EPISTAXIS 4 0.0001
950 DYSARTHRIA 2 0.0001
951 COLITIS 2 0.0001
952 HERPES ZOSTER 3 0.0001
953 EYE IRRITATION 3 0.0001
954 NEUTROPENIA 7 0.0001
955 PLASMA CELL MYELOMA 2 0.0001
956 WHEEZING 3 0.0001
957 ABNORMAL BEHAVIOUR 2 0.0001
958 ABORTION SPONTANEOUS 2 0.0000
959 DEATH 42 0.0000
960 OSTEOPOROSIS 2 0.0000
961 EXPOSURE DURING PREGNANCY 3 0.0000
962 WITHDRAWAL SYNDROME 2 0.0000
963 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
964 DEVICE MALFUNCTION 3 0.0000
965 MULTIPLE SCLEROSIS 2 0.0000
966 INTERSTITIAL LUNG DISEASE 2 0.0000
967 EMOTIONAL DISTRESS 5 0.0000
968 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
969 FLUID RETENTION 2 0.0000
970 NO ADVERSE EVENT 7 0.0000
971 DRUG DOSE OMISSION BY DEVICE 3 0.0000
972 PROSTATE CANCER 3 0.0000
973 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
974 ABNORMAL DREAMS 1 0.0000
975 TREATMENT FAILURE 3 0.0000
976 RHEUMATOID ARTHRITIS 4 0.0000
977 ADVERSE DRUG REACTION 3 0.0000
978 ADVERSE EVENT 3 0.0000
979 BREAST CANCER 3 0.0000
980 PRODUCT DOSE OMISSION 2 0.0000
981 DEVICE DIFFICULT TO USE 2 0.0000
982 HAEMOGLOBIN DECREASED 3 0.0000
983 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
985 INJURY 2 0.0000
986 SKIN BURNING SENSATION 2 0.0000
987 UNEVALUABLE EVENT 2 0.0000
988 DRUG ABUSE 2 0.0000
989 PULMONARY EMBOLISM 2 0.0000
990 BLISTER 1 0.0000
991 TOXICITY TO VARIOUS AGENTS 3 0.0000